GERM
Amplify Treatments, Testing and Advancements ETF
GERM
GERM
Delisted
GERM was delisted on the 5th of September, 2024.
24 hedge funds and large institutions have $6M invested in Amplify Treatments, Testing and Advancements ETF in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$597K | |
| 2 | +$265K | |
| 3 | +$223K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$197K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$123K |
Top Sellers
| 1 | -$237K | |
| 2 | -$172K | |
| 3 | -$13K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$9.62K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$9K |